Clinical Trials Logo

CLN6 clinical trials

View clinical trials related to CLN6.

Filter by:
  • None
  • Page 1

NCT ID: NCT04273243 Active, not recruiting - Batten Disease Clinical Trials

Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer

Start date: January 24, 2020
Phase:
Study type: Observational

This is a long-term safety and efficacy study in subjects with CLN6 Batten disease who previously received a single intrathecal administration of AT-GTX-501.

NCT ID: NCT03285425 Recruiting - Batten Disease Clinical Trials

Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae

Batten'sCLN6
Start date: January 2017
Phase:
Study type: Observational

CLN6 is a rare, neurodegenerative disease that causes progressive loss of acquired skills with motor delay, visual loss, seizures and ataxia. The investigators propose a natural history study of this rare disorder since it is currently unknown. It is important to understand disease progression in CLN6 disease to be able to judge therapeutic efficacy as emerging therapies like gene therapy become available.